4.0
1 Sept 2025
Former employee
Boston, MA
Recommend
CEO approval
Business outlook
Pros
- data sciences approaches - RPM market in provider and life sciences was exploratory in 2023
Cons
- broke up company into multiple parts and sold
Check out your Company Bowl for anonymous work chats.